Navigation Links
Perrigo Reports Record Revenue and Adjusted Earnings
Date:5/7/2013

48.7%

-300 bps 

The Rx Pharmaceuticals segment third quarter net sales increased 22% to $189 million due primarily to new product sales of $18 million, $8 million in sales related to the February 11th 2013 acquisition of Rosemont, and strong prescription volumes evidenced by an increase in existing product sales of $7 million.

The adjusted gross margin decreased due primarily to less favorable product mix. The adjusted operating margin was impacted by higher distribution, selling, general and administrative costs and the inclusion of Rosemont.

API

 

 

API Segment (in thousands)(see the attached Table II for reconciliation to GAAP numbers)Fiscal 2013

Fiscal 2012Third

 Quarter
Ended

Third

 Quarter

Ended

 

 

YoY3/30/2013

3/31/2012

% ChangeNet Sales

$41,114

$36,951

+11.3%Reported Gross Profit

$20,915

$18,675

+12.0%Adjusted Gross Profit

$21,413

$19,165

+11.7%Reported Operating Income

$11,728

$10,462

+12.1%Adjusted Operating Income

$12,226

$10,952

+11.6%Reported Gross Margin

50.9%

50.5%

+40 bpsAdjusted Gross Margin

52.1%

51.9%

+20 bpsReported Operating Margin

28.5%

28.3%

+20 bpsAdjusted Operating Margin

29.7%

29.6%

+10 bpsThe API segment's net sales increased by 11% to $41 million due to an increase in existing product sales of $4 million primarily related to the continued successful launch of a customer's product.

Operating margins expanded on favorable mix of existing product sales offset slightly by higher distribution selling, general and administrative expenses.

Closing

Chairman, President and CEO Joseph C.
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Perrigo Company To Release Third Quarter Fiscal Year 2013 Results On May 7, 2013
2. Perrigo Company To Present At The Barclays Global Healthcare Conference
3. Perrigo Company To Present At The RBC Global Healthcare Conference
4. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
5. Perrigo Company To Present At The Leerink Swann Global Healthcare Conference
6. Perrigo Company Acquires U.K.-based Rosemont Pharmaceuticals Ltd. For Approximately £180 Million Or $283 Million
7. Perrigo Confirms FDA Approval For Testosterone Gel 1%
8. Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
9. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
10. Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
11. Perrigo Company To Release Second Quarter Fiscal Year 2013 Results On February 1, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been certified ... Association, a non-profit organization assisting medically integrated health and ... Fitness & Health Center is the only certified fitness ... Chicagoland area. "The certification means the Cadence ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Loss, Non-Inferiority in Target Vessel Failure and Low Rates of MACE ... ... PARK, Ill., April 22 A study published,in today,s Journal of ... Everolimus Eluting Coronary Stent System,in patients with coronary artery disease resulted ...
... Data For Presentation At ASCO 2008, LONDON ... a wide range of new data at the ... Chicago starting Friday, May,30th. The data cover a ... treatment and supportive care of cancer,patients. At this ...
Cached Medicine Technology:Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5GlaxoSmithKline Reports Further Progress of Oncology Portfolio 2GlaxoSmithKline Reports Further Progress of Oncology Portfolio 3GlaxoSmithKline Reports Further Progress of Oncology Portfolio 4GlaxoSmithKline Reports Further Progress of Oncology Portfolio 5GlaxoSmithKline Reports Further Progress of Oncology Portfolio 6GlaxoSmithKline Reports Further Progress of Oncology Portfolio 7
(Date:4/17/2014)... PHILADELPHIA The presence of chronic inflammation in ... aggressive, prostate cancer, and this association was found ... levels, according to a study published in ... of the American Association for Cancer Research. , ... some participants of the placebo arm of the ...
(Date:4/17/2014)... PLOS Pathogens , children who live in regions of ... immune response to infection with malaria parasites that may ... and illness and partially control the growth of malaria ... develop future interventions that prevent or mitigate the disease ... 200 million cases of malaria occur worldwide, resulting in ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... 16, 2014) The cause of neuronal death in ... proposes that neurons may be mistaken for foreign invaders ... to the way autoimmune diseases like type I diabetes, ... The study was published April 16, 2014, in ... likely controversial, idea in Parkinson,s disease; but if true, ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Dual role: Key cell division proteins also power up mitochondria 2
... ... help dental practices increase their visibility & conversions online. , ... Oak Brook, IL (PRWEB) September 26, 2009 ... social networking program to help dental and medical practices gain higher visibility online and ...
... Brazilian wandering spider may improve erections, researchers say , ... discovered a novel way to treat erectile dysfunction -- ... bite from the Brazilian wandering spider (Phoneutria nigriventer) causes ... and later lead to impotence, researchers from the United ...
... in everything from problems with California,s hospitals to a perpetual ... the city will find itself deluged not only by smart ... solvers who tackle America,s greatest threats. The annual meeting of ... takes place at the San Diego Convention Center and the ...
... reports high success rate for new test, with results in ... new test can rapidly identify active tuberculosis in people who,ve ... half of all people with active TB, the disease-causing bacterium ... diagnostic tests are needed to help control the spread of ...
... created a new approach that vastly improves the ... organs. Kenneth Longmuir, associate professor of physiology ... & neurobiology, used liposomes, small spheres (less-than 100 ... "packages" for the cancer chemotherapeutic agent doxorubicin, and ...
... SEPT. 25, 2009 Journalists are invited to attend a ... care experts who will review and develop programs that may ... The symposium, which will be held Oct. 8 and 9 ... of Dimes, the American College of Obstetricians and Gynecologists, the ...
Cached Medicine News:Health News:Dental Website Marketing Firm, Officite, Launches Social Networking Program 2Health News:Dental Website Marketing Firm, Officite, Launches Social Networking Program 3Health News:Spider Venom -- The Next Way to Treat Impotence? 2Health News:4,000 numbers crunchers count on San Diego 2Health News:Faster Detection of TB May Be on the Horizon 2Health News:UCI researchers create new strategy for highly selective chemotherapy delivery 2Health News:Experts to review quality improvement programs to prevent preterm birth 2Health News:Experts to review quality improvement programs to prevent preterm birth 3
The Medtronic ULTRAFLEX™ venous cannula provides you with excellent cannula flexibility. This new, unique design provides easy maneuvering during placement and kink resistant flexibility during ...
... The DLP® One-Piece Pediatric Arterial ... in our line of pediatric ... advances over previous models such ... body and patented Flow-Guard™ introducer ...
... CAP® cannulae provides a simple solution ... An innovative combination of aortic perfusion ... the Select CAP® can provide a ... pressure readings on which you can ...
... the vitreoretinal surgeon a temporary tamponade for ... subretinal fluid, dissection of fibro-vascular proliferation and ... Eftiar Decalin liquid is indicated for use ... the retina. It is also indicated as ...
Medicine Products: